PL2200 Aspirin Capsules
PL-ASA-006
Phase 3 small_molecule completed
Quick answer
PL2200 Aspirin Capsules for Diabetes Mellitus, Type 2 is a Phase 3 program (small_molecule) at Protalix BioTherapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed